Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
601992

Multiple Sclerosis -Epidemiology Forecast to 2028
Published: Pre-Order | DelveInsight Business Research LLP | 50 Pages | Delivery time: 2-10 business days

Price

Back to Top
Multiple Sclerosis -Epidemiology Forecast to 2028
Published: Pre-Order
DelveInsight Business Research LLP
Content info: 50 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

DelveInsight's "Multiple Sclerosis - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Multiple Sclerosis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Multiple Sclerosis Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Multiple Sclerosis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Multiple Sclerosis outlook. It also includes the explanation of changing trends of epidemiology outlining the Multiple Sclerosis scenario.

Multiple Sclerosis Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Multiple Sclerosis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Multiple Sclerosis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Multiple Sclerosis Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Multiple Sclerosis

Key assessments

  • Patient Segmentation in Multiple Sclerosis
  • Multiple Sclerosis Risk & Burden
  • Factors driving growth in a specific Multiple Sclerosis patient population
Product Code: DIEI0322

Table of Contents

1. Report Introduction

2. Multiple Sclerosis Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Multiple Sclerosis in 2016
  • 2.2. Patient Share Distribution of Multiple Sclerosis in 2028

3. Disease Background and Overview: Multiple Sclerosis

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Multiple Sclerosis in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Multiple Sclerosis in 7MM - By Countries

5. Epidemiology of Multiple Sclerosis by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.1.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.1.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.1.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.4.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.4.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.4.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.5.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.5.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.5.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.6.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.6.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.6.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.7.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.7.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.7.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.8.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.8.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.8.5. Diagnosed Cases of the Multiple Sclerosis
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Multiple Sclerosis
    • 5.9.3. Sub-Type Specific cases of the Multiple Sclerosis *
    • 5.9.4. Sex- Specific Cases of the Multiple Sclerosis *
    • 5.9.5. Diagnosed Cases of the Multiple Sclerosis

6. Unmet Needs of the Multiple Sclerosis

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Multiple Sclerosis in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Multiple Sclerosis in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Multiple Sclerosis in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Multiple Sclerosis in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Multiple Sclerosis in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Multiple Sclerosis in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Multiple Sclerosis in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Multiple Sclerosis in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Multiple Sclerosis in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Multiple Sclerosis in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Multiple Sclerosis in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Multiple Sclerosis in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Multiple Sclerosis in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Multiple Sclerosis in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Multiple Sclerosis in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Multiple Sclerosis in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Multiple Sclerosis in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Multiple Sclerosis in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Multiple Sclerosis in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Multiple Sclerosis in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Multiple Sclerosis in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Multiple Sclerosis in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Multiple Sclerosis in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Multiple Sclerosis in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Multiple Sclerosis in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Multiple Sclerosis in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Multiple Sclerosis in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Multiple Sclerosis in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Multiple Sclerosis in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Multiple Sclerosis in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Multiple Sclerosis in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Multiple Sclerosis in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Multiple Sclerosis in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Multiple Sclerosis in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Multiple Sclerosis in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Multiple Sclerosis in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Multiple Sclerosis in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Multiple Sclerosis in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Multiple Sclerosis in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Multiple Sclerosis in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Multiple Sclerosis in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Multiple Sclerosis in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Multiple Sclerosis in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Multiple Sclerosis in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Multiple Sclerosis in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Multiple Sclerosis in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Multiple Sclerosis in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Multiple Sclerosis in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Multiple Sclerosis in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Multiple Sclerosis in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Multiple Sclerosis in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Multiple Sclerosis in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Multiple Sclerosis in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Multiple Sclerosis in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Multiple Sclerosis in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Multiple Sclerosis in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Multiple Sclerosis in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Multiple Sclerosis in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Multiple Sclerosis in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Multiple Sclerosis in Japan (2016-2028)